REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, Licensee has provided PHS with the Commercial Development Plan in Appendix E, under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks arc determined as specified in Appendix D.
Appears in 2 contracts
Samples: Patent License Agreement (Bavarian Nordic a/S / ADR), Patent License Agreement (Bavarian Nordic a/S / ADR)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 9.01 Prior to signing this Agreement, Licensee has provided to PHS with the Commercial Development Plan in at Appendix EF, under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks arc are determined as specified in Appendix D.
Appears in 2 contracts
Samples: Sublicense and License Agreement (Neopharm Inc), Sublicense and License Agreement (Neopharm Inc)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, Licensee has provided PHS with the Commercial Development Plan referred to in more detail in Appendix E, and under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks arc are determined as specified in Appendix D.
Appears in 2 contracts
Samples: Patent License Agreement (Merrimack Pharmaceuticals Inc), Patent License Agreement (Merrimack Pharmaceuticals Inc)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 9.01 Prior to signing this Agreement, Licensee has provided to PHS with the Commercial Development Plan in at Appendix EF, under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights and/or Biological Materials to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks arc are determined as specified in Appendix D.E.
Appears in 2 contracts
Samples: Patent License Agreement (Aridis Pharmaceuticals, Inc.), Patent License Agreement (Aridis Pharmaceuticals, Inc.)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 9.01 Prior to signing this Agreement, Licensee has provided to PHS with the Commercial Development Plan in at Appendix EF, under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights to the point of Practical Application. This The Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Performance and Benchmarks arc are determined as specified in Appendix D.E.
Appears in 1 contract
Samples: Patent License Agreement (Genencor International Inc)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 9.01 Prior to signing this Agreement, Licensee has provided to PHS with the Commercial Development Plan in at Appendix EF, under which Licensee intends to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights and/or Background Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks arc are determined as specified in Appendix D.E.
Appears in 1 contract
Samples: Public Health Service (Neopharm Inc)